AOD 9604 – 5mg (Research-Grade Peptide)
Modified Fragment of Human Growth Hormone (176–191)
For Research Use Only
AOD 9604 is a synthetic peptide fragment derived from the C-terminal end of human growth hormone (hGH), specifically amino acids 176–191. It was developed to isolate the fat-reducing effects of hGH without the associated anabolic activity, making it a key compound in the study of lipid metabolism and weight regulation.
In research settings, AOD 9604 has shown potential to enhance lipolysis (fat breakdown) and inhibit lipogenesis (fat formation), with minimal impact on blood sugar or IGF-1 levels. Its selective action makes it a promising candidate for obesity and metabolic function research.
Each vial contains:
AOD 9604 – 5mg (Lyophilized Powder)
Research Applications May Include:
• Investigation of fat metabolism and adipose tissue regulation
• Lipolysis stimulation without anabolic side effects
• Study of obesity-related mechanisms in animal models
• Exploration of metabolic homeostasis and insulin sensitivity
• Evaluation of growth hormone fragment pathways
AOD 9604 is provided as a lyophilized powder intended strictly for research use. Not for human or veterinary consumption. Not approved for therapeutic or diagnostic use.
Storage: Reconstitute with sterile or bacteriostatic water. Store refrigerated after mixing.
💧 Includes 3ml vial of bacteriostatic water
🔬 Chemical Information (AOD 9604):
• Synonyms: hGH Fragment 176–191
• CAS Number: 221231-10-3
• Molecular Formula: C₇₈H₁₂₃N₂₃O₂₃S₂
• Molecular Weight: ≈1815 Da
• Purity: ≥99% (Peptide-Grade)
🔬 Regenix Peptides – Research Excellence in Every Vial
🚚 Next Day Delivery – Order before 12pm for tracked UK shipping
🧪 Research-Grade Purity – Trusted compounds, independently tested (≥99% purity)
📦 Discreet Packaging – No compound names on label or shipping box
✅ In-Stock & Ready to Ship – UK-based for fast turnaround
🧬 For Research Purposes Only – Not for human consumption
